| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8794914 | Ophthalmology Retina | 2017 | 9 Pages |
Abstract
After MH closure with ocriplasmin, subfoveal lucency width was greater than pretreatment MH and persisted longer during follow-up compared with placebo or PPV. Subfoveal lucency was not a marker for visual function regardless of treatment group.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Francisco A. MD, Glenn J. MD, Cynthia A. MD, Tamer H. MD, PhD,